Concepedia

Aleksandra Berkan‐Kawińska

AB

Statistics

Publications

9

Citations

201

H-Index

9

Active since

2019

Affiliations

Medical University of Silesia(Current)

Medical University of Białystok

Medical University of Lublin

Nicolaus Copernicus University

Jan Kochanowski University

Aleksandra Berkan‐Kawińska is an author at Medical University of Silesia specializing in pharmacotherapy, antiviral therapy, and infectious diseases.

ORCID

Publications per year

2019–2022

9

Publications

9

Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity

Chiara Fallerini, Nicola Picchiotti, Margherita Baldassarri et al. · Human Genetics · 2021 · 41 citations · Full text

, , +17

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska et al. · Journal of Clinical Medicine · 2021 · 29 citations · Full text

, , +17

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study

Dorota Zarębska‐Michaluk, Jerzy Jaroszewicz, Magdalena Rogalska et al. · Journal of Inflammation Research · 2021 · 28 citations · Full text

, , +14

Impact of Kidney Failure on the Severity of COVID-19

Dorota Zarębska‐Michaluk, Jerzy Jaroszewicz, Magdalena Rogalska et al. · Journal of Clinical Medicine · 2021 · 23 citations · Full text

, , +14

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

Robert Flisiak, Dorota Zarębska‐Michaluk, Aleksandra Berkan‐Kawińska et al. · Polskie Archiwum Medycyny Wewnętrznej · 2020 · 22 citations · Full text

, , +17

1–5 of 9